Diabetes technology

Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues

J Diabetes Sci TechnolPublished Scoping review

Authors' conclusion

More studies are required in which the feasibility, benefits and limitations of FGM and CGM in non-intensive care unit hospital settings are elucidated. We need evidence on which types of hospital wards might benefit from the introduction of this technology and the contexts in which they are less useful. We also need to identify the types of people who are most likely to find FGM and CGM useful for self-management and for which populations they have the most benefit in terms of clinical outcomes and length of stay.

Study context

Population
People with diabetes in non-ICU (general ward) hospital settings
Outcome
Benefits and issues of CGM and flash glucose monitoring (FGM) on general wards

Main finding

As reported in the abstract

  • Continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) on general wards could lead to improved glycemic control, decreased LOS, and reduced risk of severe hypoglycemia or hyperglycemia
  • Potential problems: lack of experience with this technology and costs of sensors
  • Rapid analysis of glucose measurements can facilitate clinical decision making and therapy adjustment in hospital
  • People with diabetes may be empowered to better self-manage in hospital via direct access to their glucose data

Original publication

Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues. J Diabetes Sci Technol. Published 25 October 2021. doi:10.1177/19322968211053652

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.